Corneal Flap Transplantation for Macular Hole Repair of High Myopia

Myopia, Degenerative Clinical Trial

Official title: Corneal Flap Transplantation for Macular Hole Repair of High Myopia

Status Active, not recruiting

Clinical Trial Summary

The goal of this clinical trial is to learn about an innovative surgical technique for macular hole repair. This technique is for patients with high myopia using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The main questions it aims to answer are:

• Is the innovative surgical technique useful for patients?

• Is the surgical technique safe for patients?

Participants will:

• Undergo PPV combined with corneal flap transplantation to cover the macular hole.

• Maintain a prone position for 2 weeks postoperatively.

• Be observed by visual acuity, slit lamp, optical coherence tomography (OCT) and fundus photography for 1 year after surgery.

Clinical Trial Description

We describe an innovative surgical technique for macular hole repair using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The corneal flap was sealed with autologous blood. The vitreous cavity was then filled with perfluoropropane (C3F8) or sterile air. ;

Related Conditions & MeSH terms

• Myopia
• Myopia, Degenerative
• Retinal Perforations

• NCT number: NCT05875909
• Study type: Interventional
• Source: First People's Hospital of Hangzhou
• Status: Active, not recruiting
• Phase: N/A
• Start date: February 23, 2022
• Completion date: December 31, 2025